aap Implantate (AAQ.DE) stock price, revenue, and financials

aap Implantate market cap is €12.2 m, and annual revenue was €12.64 m in FY 2018

€12.2 M

AAQ.DE Mkt cap, 09-Jul-2020

€3 M

aap Implantate Revenue Q2, 2019
aap Implantate Gross profit (Q2, 2019)2.6 M
aap Implantate Gross profit margin (Q2, 2019), %85.3%
aap Implantate Net income (Q2, 2019)-3.1 M
aap Implantate EBITDA (Q2, 2019)-2.1 M
aap Implantate EBIT (Q2, 2019)-2.7 M
aap Implantate Cash, 30-Jun-20195.2 M
aap Implantate EV10.8 M

aap Implantate Revenue

aap Implantate revenue was €12.64 m in FY, 2018 which is a 8.3% year over year increase from the previous period.

Embed Graph

aap Implantate Revenue Breakdown

Embed Graph

aap Implantate revenue breakdown by geographic segment: 53.6% from International, 20.7% from North America and 25.6% from Germany

aap Implantate Income Statement

Annual

EURFY, 2017FY, 2018

Revenue

11.7m12.6m

Revenue growth, %

8%

Cost of goods sold

1.9m2.3m

Gross profit

9.8m10.3m

Gross profit Margin, %

84%81%

General and administrative expense

7.4m7.8m

Operating expense total

18.5m11.1m

Depreciation and amortization

1.8m1.7m

EBITDA

(6.2m)(6.4m)

EBITDA margin, %

(53%)(51%)

EBIT

(8.0m)(8.1m)

EBIT margin, %

(69%)(64%)

Interest expense

48.0k30.0k

Interest income

3.0k

Pre tax profit

(9.3m)(7.6m)

Income tax expense

(29.0k)18.0k

Net Income

(9.3m)(7.7m)

EPS

(0.1)(0.3)

Quarterly

EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

2.7m3.2m3.4m3.0m3.0m

Cost of goods sold

492.0k630.0k573.0k397.0k441.0k

Gross profit

2.2m2.5m2.8m2.6m2.6m

Gross profit Margin, %

82%80%83%87%85%

General and administrative expense

2.0m2.0m2.1m1.9m2.5m

Operating expense total

4.3m4.7m4.8m4.2m5.7m

Depreciation and amortization

410.0k422.0k441.0k571.0k589.0k

EBITDA

(1.6m)(1.5m)(1.5m)(998.0k)(2.1m)

EBITDA margin, %

(59%)(48%)(44%)(33%)(71%)

EBIT

(2.0m)(2.0m)(1.9m)(1.6m)(2.7m)

EBIT margin, %

(74%)(62%)(57%)(52%)(91%)

Pre tax profit

(2.2m)(1.5m)(1.9m)(1.3m)(2.9m)

Income tax expense

7.0k(83.0k)1.0k164.0k

Net Income

(2.2m)(1.4m)(1.9m)(1.3m)(3.1m)

aap Implantate Balance Sheet

Annual

EURFY, 2017FY, 2018

Cash

13.3m4.3m

Accounts Receivable

2.5m2.7m

Inventories

9.6m9.6m

Current Assets

28.8m19.7m

PP&E

7.2m6.9m

Total Assets

50.5m42.2m

Accounts Payable

1.8m2.1m

Short-term debt

2.3m1.8m

Current Liabilities

5.1m4.7m

Long-term debt

749.0k343.0k

Non-Current Liabilities

2.8m2.6m

Total Debt

3.0m2.1m

Common Stock

28.6m28.7m

Additional Paid-in Capital

31.6m31.8m

Retained Earnings

(18.0m)(25.7m)

Total Equity

42.6m34.9m

Debt to Equity Ratio

0.1 x0.1 x

Debt to Assets Ratio

0.1 x0.1 x

Financial Leverage

1.2 x1.2 x

Quarterly

EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

11.2m9.5m7.3m2.7m5.2m

Accounts Receivable

2.4m2.5m2.8m2.5m1.6m

Inventories

8.9m9.1m9.3m8.9m9.1m

Current Assets

26.0m24.5m22.6m17.4m19.5m

PP&E

7.1m7.0m6.8m6.7m6.6m

Total Assets

47.4m46.3m44.6m41.0m43.4m

Accounts Payable

1.4m2.1m2.1m1.8m2.2m

Short-term debt

1.6m1.7m1.7m1.2m1.4m

Current Liabilities

4.3m4.8m5.0m4.0m4.7m

Long-term debt

663.0k591.0k510.0k1.2m2.3m

Non-Current Liabilities

2.7m2.5m2.4m3.5m4.7m

Total Debt

2.3m2.3m2.2m2.4m3.7m

Common Stock

28.6m28.6m28.7m28.7m32.1m

Additional Paid-in Capital

31.7m31.7m31.7m31.8m31.9m

Retained Earnings

(20.3m)(21.6m)(23.5m)(27.0m)(30.1m)

Total Equity

40.4m38.9m37.2m33.5m33.9m

Debt to Equity Ratio

0.1 x0.1 x0.1 x0.1 x0.1 x

Debt to Assets Ratio

0 x0 x0 x0.1 x0.1 x

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.3 x

aap Implantate Cash Flow

Annual

EURFY, 2017FY, 2018

Net Income

(9.3m)(7.7m)

Depreciation and Amortization

1.8m1.7m

Accounts Receivable

400.0k(100.0k)

Inventories

1.4m300.0k

Accounts Payable

(800.0k)400.0k

Cash From Operating Activities

(5.4m)(5.9m)

Capital Expenditures

(701.0k)(810.0k)

Cash From Investing Activities

(1.5m)(3.0m)

Long-term Borrowings

(1.4m)(799.0k)

Cash From Financing Activities

(3.5m)(159.0k)

Net Change in Cash

(10.5m)(9.0m)

Interest Paid

48.0k30.0k

Income Taxes Paid

(2.0k)11.0k

Free Cash Flow

(6.1m)(6.7m)

Quarterly

EURQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(2.2m)(3.6m)(5.5m)(1.3m)(4.4m)

Depreciation and Amortization

410.0k832.0k1.3m571.0k1.2m

Accounts Receivable

200.0k(300.0k)100.0k1.1m

Inventories

500.0k500.0k300.0k900.0k600.0k

Accounts Payable

(400.0k)300.0k300.0k(400.0k)100.0k

Cash From Operating Activities

(1.4m)(2.3m)(3.7m)(468.0k)(1.8m)

Capital Expenditures

(155.0k)(330.0k)(437.0k)(162.0k)(308.0k)

Cash From Investing Activities

(484.0k)(1.3m)(2.1m)(958.0k)(1.5m)

Long-term Borrowings

(197.0k)(385.0k)(574.0k)(40.0k)(580.0k)

Cash From Financing Activities

(204.0k)(120.0k)(174.0k)(171.0k)4.2m

Net Change in Cash

(2.1m)(3.7m)(6.0m)(1.6m)896.0k

Interest Paid

8.0k14.0k19.0k4.0k23.0k

Income Taxes Paid

7.0k7.0k7.0k

Free Cash Flow

(1.5m)(2.6m)(4.2m)(630.0k)(2.1m)

aap Implantate Ratios

EURFY, 2017

Revenue/Employee

82.8k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x

aap Implantate Operating Metrics

FY, 2017Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019

Countries

25 25 25 25 25 25 25

aap Implantate Employee Rating

1.86 votes
Culture & Values
1.8
Work/Life Balance
2.3
Senior Management
1.3
Salary & Benefits
2.1
Career Opportunities
1.7
Source